Intracameral phenylephrine: the answer to floppy iris syndrome?
Intracameral phenylephrine is a straightforward and effective way to prevent the effects of floppy iris syndrome in patients taking systemic tamsulosin and undergoing cataract surgery.
Intracameral phenylephrine is a straightforward and effective way to prevent the effects of floppy iris syndrome in patients taking systemic tamsulosin and undergoing cataract surgery, according to a study published in the March issue of Eye.
Avinash Gurbaxani and Richard Packard from the King Edward VII Hospital, Berkshire, UK, examined seven patients who were receiving systemic tamsulosin for benign prostatic hypertrophy. Each subject was given intracameral phenylephrine before capsulorhexis during cataract surgery.
The authors observed that there was a significant reduction in the mobility of the iris, reduction in the expected fluttering and sustained papillary dilation.
The results of this study suggest that intracameral phenylephrine can be a useful tool for preventing the effects of floppy iris syndrome in patients receiving systemic tamsulosin while undergoing cataract surgery.
AAO 2024: Transient vision loss with Alexander Fein, MD
October 21st 2024Alexander Fein, MD, spoke with the Eye Care Network to share how to approach a patient presenting with transient vision loss, what this type of vision loss can mean, and what additional testing might be needed to determine the best plan for care.
AAO 2024: Optimal pupil size reduction percentage for near vision improvement in presbyopia
October 21st 2024Jennifer Loh, MD, shared insights from on her presentation at the American Academy of Ophthalmology meeting in Chicago on the effects of CSF-1, which is the lowest effective concentration of pilocarpine approved in the United States.
